Doç.Dr.Umut ARSLAN
Ophthalmologist, Retina Specialist,
Regenerative ophthalmologist
Education
University: Istanbul University, Faculty of Medicine / 1994-2000
Speciality: Ankara University, Faculty of Medicine, Department of Ophthalmology / 2000-2004
His specialty is regenerative, restorative, stem cell, growth factors and electromagnetic stimulation applications in the treatment of retinal and optic nerve diseases.
ORCID: 0000-0003-4146-8083
Employment
Ankara Üniversitesi: Ankara, Ankara, TR
Researcher (Technology Research and Development Center)
Employment
Education and qualifications
Ankara Üniversitesi: Ankara, Ankara, TR
MD (Faculty of medicine)
Education
Invited positions and distinctions
Ankara Üniversitesi: Ankara, Ankara, TR
Ophthalmologist, researcher (Bioretina Biyoteknoloji Inc. Technopolis)
Works
Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation
Stem Cell Research & Therapy
2021-12 | Journal article
DOI: 10.1186/s13287-021-02577-2
Investigation of genotype–phenotype relationship in Turkish patients with inherited retinal disease by next generation sequencing
Ophthalmic Genetics
2021-11-02 | Journal article
DOI: 10.1080/13816810.2021.1952616
Evaluation of the effect of subtenon autologous platelet-rich plasma injections on visual functions in patients with retinitis pigmentosa
Regenerative Medicine
2021-02-23 | Journal article
DOI: 10.2217/rme-2020-0075
Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results
Stem Cell Research & Therapy
2020-12 | Journal article
DOI: 10.1186/s13287-020-01870-w
PMID: PMID: 32787913
Effect of autologous growth factors on apoptosis and thickness of the outer nuclear layer in an experimental retinal degeneration model
Growth Factors
2020-11-01 | Journal article
DOI: 10.1080/08977194.2021.1948842
Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation
Regenerative Medicine
2020-10-27 | Journal article
DOI: 10.2217/rme-2020-0056
PMID: 33107400
Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser.
Lasers in medical science
2020-05-04 | Journal article
PMID: 32363437
DOI: 10.1007/s10103-020-03031-0
Management of Retinitis Pigmentosa via Platelet-Rich Plasma or Combination with Electromagnetic Stimulation: Retrospective Analysis of 1-Year Results.
Advances in therapy
2020-04-18 | Journal article
PMID: 32303913
DOI: 10.1007/s12325-020-01308-y
Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results.
Stem cell research & therapy
2020-01-13 | Journal article
PMID: 31931872
PMC: PMC6958670
DOI: 10.1186/s13287-020-1549-6
Retinal Prostheses and Artificial Vision
Turkish journal of ophthalmology
2019-09-01 | Journal article
PMID: 31486609
PMC: PMC6761377
DOI: 10.4274/tjo.galenos.2019.44270
Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet-Rich Plasma: Preliminary Clinical Results.
Advances in therapy
2019-08-05 | Journal article
PMID: 31385285
DOI: 10.1007/s12325-019-01040-2
Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2018-03-15 | Journal article
PMID: 29546474
DOI: 10.1007/s00417-018-3953-5
Dissociated vertical deviation and its relationship with time and type of surgery in infantile esotropia.
The British journal of ophthalmology
2010-06-01 | Journal article
PMID: 20508049
DOI: 10.1136/bjo.2008.157016
Peer review
Review activity for Stem cell research & therapy. (18)
Wissenschaftliche Publikationen und Präsentationen:
Klicken Sie hier für Internationale wissenschaftliche Publikationen
Preise für wissenschaftliche Forschung
WIR WURDEN AUF DEM NATIONALEN OPHTHALMOLOGIE-KONGRESS 2020 VON DER TÜRKISCHEN OPHTHALMOLOGIE-GESELLSCHAFT MIT ZWEI WISSENSCHAFTLICHEN FORSCHUNGSPREISEN AUSGEZEICHNET. UNSER DANK AN DIE LIEBEN MITGLIEDER DER JURY.
Unsere Publikation zum Thema „Stammzellen und Magnovision bei der Behandlung von Optikusneuropathie aufgrund einer Methylalkoholvergiftung“ gewann den ersten Preis bei der Bewertung der Publikation im Jahr 2021 beim Aprilkurs 2022 der Turkish Ophthalmology Society. Wir danken den Mitgliedern der Jury.
Kommunikation:
TEL: 0505 502 51 66
ADRESSE: NEORAMA BUSINESS CENTER BÜRO 56 STOCK 11 LIFE AVENUE NO 13 SÖĞÜTÖZÜ-BEŞTEPE/ANKARA